Skip to main content

Table 3 The multivariate analysis of neuropathic pain among patients with NMOSD. (neuropathic pain as dependent variable)

From: The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study

 

Crude

 

Adjusted model

 
 

OR (95% CI)

P value

OR (95% CI)

P value

Age at the onset, each 5 years

1.30(1.08–1.56)

0.006

1.35(1–1.81)

0.05

Gender, female

2.21(0.54–8.99)

0.267

12.11(0.97–151.64)

0.053

Optic neuritis

0.34(0.12–0.92)

0.034

0.43(0.05–3.66)

0.443

Upper thoracic lesionsa

3.00(1.08–8.32)

0.035

0.75(0.11–4.97)

0.763

≥ 4 thoracic lesionsa

7.90(2.01–30.95)

0.003

20.21(1.18–346.05)

0.038

EDSS

1.07(0.90–1.28)

0.435

1.19(0.91–1.56)

0.216

Intravenous immunoglobulin

4.91(1.41–17.13)

0.013

2.43(0.5–11.73)

0.269

MMF

3.62(1.02–12.86)

0.047

7.32(0.83–64.15)

0.072

  1. Adjusted for age at the onset, gender, optic neuritis, upper thoracic lesions, ≥ 4 thoracic lesions, EDSS, Intravenous immunoglobulin, MMF
  2. AQP4-IgG Aquaporin-4 immunoglobulin G, Th Thoracic, Th1-Th6 Upper thoracic lesions, EDSS Extended disability status Scale, MMF Mycophenolate mofetil
  3. a Missing 19 cases